HIGHLIGHTS
- who: Nicole Maynard from the Keck School of Medicine of USC, Zonal KAM, MC, Los Angeles, CA, USA have published the research: The Impact of Immune-Modulating Treatments for Dermatological Diseases on the Risk of Infection with SARS-CoV-2 and Outcomes Associated with COVID-19 Illness, in the Journal: (JOURNAL)
- what: Before the data for COVID-19 became available, the research community first focused on the relationship between TNFi and the risk of respiratory tract infections.
SUMMARY
In a 2020 retrospective observational study in Verona, Italy, researchers investigated the risk . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.